MARKET PULSE-Aeroflex, Intercept Pharma, Ambarella, Vodafone
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were little changed on Tuesday. Dow Jones industrial average futures were up 0.02 percent at 16,485, S&P 500 futures were up 0.02 percent at 1,882.7 and Nasdaq 100 futures were up 0.09 percent at 3,616.5.
** AEROFLEX HOLDING CORP, Monday close $8.31, +25.75 pct premarket
British aerospace and defense supplier Cobham is buying U.S. communications equipment maker Aeroflex Holding Corp for $1.46 billion, continuing its quest for more commercial customers as its main defense clients cut spending.
** INTERCEPT PHARMA, Monday close $260, -14.23 pct premarket
An article on Street.com alleged that the drugmaker had intentionally downplayed the side effects of its liver disease drug in a mid-stage trial that it stopped in January citing highly positive data. (link.reuters.com/cuw49v)
At the time, Intercept's stock had quadrupled to a life high of $305.